Melanoma Incidence among Non-Hispanic Whites in All 50 US States from 2001 Through 2015

Journal of the National Cancer Institute

Volumn 112, Issue 5, 2020, Pages 533-539

  Thrift, Aaron P ^a   Gudenkauf, Franciska J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BIRTH; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; UNITED STATES; VERY ELDERLY; YOUNG ADULT; ETHNOLOGY; INCIDENCE; REGISTER; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; REGISTRIES; SKIN NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 85077550545     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djz153     Document Type: Article

References (26)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34.
2. Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Melanoma thickness and survival trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2015;108(1). pii: djv294.
3. Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016;136(6):1161-1171.
4. Olsen CM, Green AC, Pandeya N, Whiteman DC. Trends in melanoma incidence rates in eight susceptible populations through 2015. J Invest Dermatol. 2019;139(6):1392-1395.
5. Printz C. Changes underway for SEER: program leaders work to increase the breadth and depth of information. Cancer. 2015;121(18):3183-3184.
6. Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of trends in US melanoma incidence and mortality. JAMA Dermatol. 2017;153(2):225-226.
7. Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA. Melanoma burden and recent trends among non-Hispanic whites aged 15-49 years, United States. Prev Med. 2016;91:294-298.
8. U.S. Department of Health and Human Services. Reports of the surgeon general. In: The Surgeon General's Call to Action to Prevent Skin Cancer. Washington, DC: Office of the Surgeon General (US); 2014.
9. Lazovich D, Choi K, Vogel RI. Time to get serious about skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1893-1901.
10. National Cancer Institute Surveillance, Epidemiology, and End Results Program SEER 18 Regs Research Data, Nov 2017 Sub (2001-2015). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. http://www.seer.cancer.gov. Accessed September 15, 2018.
11. US Cancer Statistics Working Group. US Cancer Statistics Data Visualizations Tool, Nov 2017 Sub (1999-2015). US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. www.cdc.gov/cancer/dataviz. Accessed March 5, 2019.
12. Noone AM, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2015. Bethesda, MD: National Cancer Institute; 2018.
13. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547-569.
14. Yu B, Barrett MJ, Kim H-J, Feuer EJ. Estimating joinpoints in continuous time scale for multiple change-point models. Comput Stat Data Anal. 2007;51(5): 2420-2427.
15. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
16. Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296-2302.
17. McCullagh P, Nelder JA. Generalized Linear Models. New York: Chapman and Hall; 1989.
18. Mounessa JS, Caravaglio JV, Dellavalle RP. Comparison of regional and state differences in melanoma rates in the United States: 2003 vs 2013. JAMA Dermatol. 2017;153(3):345-347.
19. Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic whites in the United States, 2005 to 2014. JAMA Dermatol. 2018;154(3):361-362.
20. Centers for Disease Control and Prevention (CDC). Skin Cancer Prevention Progress Report 2018. Atlanta, GA: CDC, US Dept of Health and Human Services; 2018.
21. El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens-part D: radiation. Lancet Oncol. 2009;10(8):751-752.
22. Guy GP Jr, Berkowitz Z, Everett Jones S, Holman DM, Garnett E, Watson M. Trends in indoor tanning among US high school students, 2009-2013. JAMA Dermatol. 2015;151(4):448-450.
23. Guy GP, Jr., Berkowitz Z, Holman DM, Hartman AM. Recent changes in the prevalence of and factors associated with frequency of indoor tanning among US adults. JAMA Dermatol. 2015;151(11):1256-1259.
24. National Conference of State Legislatures. Indoor tanning restrictions for minors. A state-by-state comparison, 2019. http://www.ncsl.org/research/health/indoor-tanning-restrictions.aspx. Accessed March 26, 2019.
25. Hartman AM, Guy GP Jr, Saraiya M, Plescia M. Use of indoor tanning devices by adults-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(18): 323-326.
26. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94(20):1537-1545.